Molly Chiaramonte

Corporate Officer/Principal at

RP Management LLC

Finance

Consumer Services

Health Technology

Profile

Molly Chiaramonte is currently working as the Vice President-Research & Investments at RP Management LLC since 2011.
Prior to this, she worked as a Senior Vice President-Research & Investments at Royalty Pharma Plc from 2008 to 2021.
Before that, Molly was a Research Associate at Jefferies LLC from 2006 to 2008.
She completed her undergraduate degree at Providence College and holds graduate and doctorate degrees from The University of Colorado.

Molly Chiaramonte active positions

Companies	Position	Start
RP Management LLC RP Management LLC Financial ConglomeratesFinance Provides biopharma royalty transactions services	Corporate Officer/Principal	23/11/2011

All active positions of Molly Chiaramonte

Former positions of Molly Chiaramonte

Companies	Position	End
ROYALTY PHARMA PLC	Corporate Officer/Principal	01/06/2021
Jefferies LLC Jefferies LLC Investment Banks/BrokersFinance Provides brokerage services	Analyst-Equity	30/04/2008

See the detail of Molly Chiaramonte's experience

Training of Molly Chiaramonte

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Molly Chiaramonte's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	5
Jefferies LLC Jefferies LLC Investment Banks/BrokersFinance Provides brokerage services	Finance
Providence College Providence College Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
The University of Colorado The University of Colorado Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
RP Management LLC RP Management LLC Financial ConglomeratesFinance Provides biopharma royalty transactions services	Finance
Royalty Pharma Plc Royalty Pharma Plc Pharmaceuticals: MajorHealth Technology Buys and operates a portfolio of biopharmaceutical royalties	Health Technology